PAP Devices Market to Be Worth $6.63 Billion by 2030

Published August 17, 2023

According to a new market research report titled, PAP Devices Market by Type [CPAP, BiPAP, APAP, Accessories (Masks, Headgear)], Disease [Obstructive Sleep Apnea, COPD, Respiratory Failure, Heart Failure], End User [Hospitals and Sleep Clinics, Home Healthcare Settings] - Global Forecast to 2030,’ published by Meticulous Research®, the PAP devices market is projected to reach $6.63 billion by 2030, at a CAGR of 5.2% from 2023 to 2030.

Positive airway pressure (PAP) devices pump air under pressure into the airway of the lungs. These devices prevent airways from collapsing, which may slow down breathing in people with respiratory problems such as obstructive sleep apnea. (OSA). Positive airway pressure (PAP) devices are used in hospitals, sleep clinics, and home healthcare settings to treat adult and pediatric or neonatal patients. Types of PAP devices include continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BiPAP) devices, and automatic positive airway pressure (APAP) devices.

Download Free Report Sample Now

The growth of this market is driven by factors the increasing prevalence of respiratory and sleep disorders, increasing breathing problems associated with the geriatric population, increasing approvals for sleep apnea devices, growing awareness about the adverse impacts of untreated sleep apnea, and favorable reimbursement policies for sleep apnea therapies and devices. However, the high costs of positive airway pressure (PAP) devices and difficulties in using positive airway pressure (PAP) devices in patients with severe nosebleed problems, allergies to latex, claustrophobia, and bullous lung disease restrain the market’s growth.

Furthermore, the growing demand for home sleep apnea tests and technological advancements in positive airway pressure (PAP) devices and therapies are expected to offer significant market growth opportunities. However, the side effects of PAP devices pose a major challenge to the market’s growth.

Product Launches and Approvals to Boost the Growth of the PAP Devices Market

A positive airway pressure (PAP) device helps sleep apnea patients by blowing pressurized air through the airway to keep the throat open. According to the National Institutes of Health (NIH), in 2020, 26% of people in the U.S. aged 30–70 years were affected by sleep apnea.

PAP devices keep patients’ airways open while sleeping, allowing them to breathe the oxygen they require for optimal functioning. Therefore, various PAP devices are adopted to induce better sleep and treat other sleep-related conditions. Key players are focused on product launches and approvals to strengthen their positions in the market. For instance:

  • In March 2023, Inspire Medical Systems, Inc. (U.S.) received U.S. Food and Drug Administration (FDA) approval for its Inspire therapy for pediatric patients with obstructive sleep apnea.
  • In August 2021, ResMed Inc. (U.S.) launched the AirSense 11 PAP Series devices to improve the treatment and management of sleep apnea.

Such developments are expected to drive the growth of this market.

The PAP devices market is segmented based on Product (Continuous Positive Airway Pressure (CPAP) Devices, Bilevel Positive Airway Pressure (BiPAP) Devices, Automatic Positive Airway Pressure (APAP) Devices, Accessories [Masks {Full Face Masks, Nasal Masks, Nasal Pillows/Cushion Masks}, Headgear, Other Accessories]), Application (Obstructive Sleep Apnea (OSA), Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Heart Failure), End User (Hospitals and Sleep Clinics, Home Healthcare Settings), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.

Speak to our Analysts: 

The report also includes an extensive assessment of the key growth strategies adopted by leading market players in the last three to four years. Some of the key players operating in the PAP devices market are ResMed Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Inspire Medical Systems, Inc. (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Rotech Healthcare Inc. (U.S.), Cardinal Health, Inc. (U.S.), Invacare Corporation (U.S.), Cleveland Medical Devices Inc. (U.S.), BMC Medical Co., Ltd. (China), Löwenstein Medical Technology GmbH + Co. KG. (Germany), SomnoMed, Inc. (Australia), Drive DeVilbiss Healthcare Ltd. (U.S.), and SunMed, LLC (U.S.).

Based on product, in 2023, the CPAP devices segment is expected to account for the largest share of the PAP devices market. The high adoption of CPAP devices for the first-line treatment of sleep disorders due to the benefits of CPAP devices, such as non-invasiveness, high effectiveness, increased mental alertness and better mood, faster control of sleep disorders, and improved sleep quality, support the segment’s large market share market.

Based on disease, in 2023, the obstructive sleep apnea (OSA) segment is expected to account for the largest share of the PAP devices market. Initiatives supporting the early diagnosis, screening, and treatment of obstructive sleep apnea and increasing awareness about the treatment and adverse effects of obstructive sleep apnea contribute to the segment’s large market share.

Based on end user, in 2023, the hospitals and sleep clinics segment is expected to account for the largest share of the PAP devices market. PAP devices improve sleep quality, minimize morning headaches and sleep interruption, and help reduce snoring. Hence, hospitals and sleep clinics prefer advanced PAP devices over other devices. Additionally, the increasing prevalence of co-morbidities such as obesity and cardiovascular disorders, the rising number of undiagnosed sleep apnea patients, and the large pool of patients with sleep apnea syndrome visiting hospitals & sleep clinics for diagnosis support the segment’s large market share.

Based on geography, the PAP devices market is segmented into North America (U.S., Canada), Europe (Germany, France, the U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the PAP devices market. North America’s large market share can be attributed to the increasing demand for PAP devices and the higher adoption of advanced medical devices in the region. Moreover, the increasing number of organic and inorganic developments by key players, such as product launches, product approvals, and acquisitions, is expected to contribute to the growth of this regional market.

However, Asia-Pacific is expected to witness rapid growth during the forecast period. Increasing government spending on healthcare in countries such as China, India, Singapore, and South Korea, technological advancements in PAP devices, and increasing government initiatives to promote awareness are driving the growth of the PAP devices market in Asia-Pacific. Furthermore, government initiatives supporting the development of healthcare facilities and increasing awareness about sleep disorders and respiratory disorders are also boosting the growth of this regional market.

To gain more insights into the market with a detailed table of content and figures, click here:

Scope of the Report:

PAP Devices Market Size & Trends Analysis - by Product

  • Continuous Positive Airway Pressure (CPAP) Devices
  • Bilevel Positive Airway Pressure (BiPAP) Devices
  • Automatic Positive Airway Pressure (APAP) Devices
  • Accessories
    • Masks
      • Full Face Masks
      • Nasal Masks
      • Nasal Pillows/Cushion Masks
    • Headgear
    • Other Accessories

Note: Other accessories include air filters, CPAP pillow, nasal pads, and power adapters & batteries.
PAP Devices Market Size & Trends Analysis - by Disease

  • Obstructive Sleep Apnea (OSA)
  • Respiratory Failure
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Heart Failure

PAP Devices Market Size & Trends Analysis -by End User

  • Hospitals and Sleep Clinics
  • Home Healthcare Settings

PAP Devices Market Size & Trends Analysis -by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Quick Buy :


Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding, 
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- [email protected] 
Visit Our Website:
Connect with us on LinkedIn-